TipRanks on MSN
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges
Rad Laboratories ( (BIO) ) has provided an announcement. On October 29, 2025, Bio-Rad Laboratories reported its financial results for the third quarter ended September 30, 2025. Despite challenges in ...
Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...
Bio-Rad Laboratories, Inc. (BIO) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $1.9 ...
The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...
Zacks Investment Research on MSN
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
Bio-Rad Laboratories, Inc. BIO posted third-quarter 2025 adjusted earnings per share (EPS) of $2.26, which missed the Zacks ...
In September 2025, BioWorld recorded 230 clinical trial updates spanning phases I through III, up sharply from 95 in August, 140 in July and just below 254 in June. Among these, 22 phase III trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback